NxThera's Series C - IV Round

NxThera raised a round of funding on February 03, 2017.

NxThera developed its Convective Water Vapor Energy (WAVE) technology platform to treat a variety of endourological conditions beginning with BPH. NxThera's FDA cleared Rezūm System to treat BPH uses…

Articles about NxThera's Series C - IV Round: